424 EUR
3.1
0.74%
Last update Dec 16, 8:00 AM CET
Main market
Day range
424
424
Previous close
420.89999
Open
424
Access this stock data via API
Subscribe
United Therapeutics Corporation
424.00
3.10
0.74%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.5B 2.3B 1.9B 1.7B
Cost of revenue 263.9M 257.5M 151.6M 122.5M
Gross profit 2.2B 2.1B 1.8B 1.6B
Operating expense
Research & development 409.9M 408M 322.9M 540.1M
Selling general and admin 544.2M 477.1M 482.1M 467M
Other operating expenses
Operating income 1.2B 1.2B 979.7M 555.9M
Non operating interest income
Income 169.7M 162.7M 45.2M 16.7M
Expense 36.6M 59.3M 32.4M 18.6M
Other income expense -55.7M -14M -41.9M 39.9M
Pretax income 1.3B 1.3B 950.6M 593.9M
Tax provision 293.1M 289.5M 223.3M 118.1M
Net income 1.0B 984.8M 727.3M 475.8M
Basic EPS 26.4 21.0 16.0 10.6
Diluted EPS 24.6 19.8 15 10.1
Basic average shares 38.5M 49.1M 47.4M 46.7M
Diluted average shares 38.5M 49.1M 47.4M 46.7M
EBITDA 1.5B 1.4B 1.0B 664.7M
Net income from continuing op. 1.0B 984.8M 727.3M 475.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 51 minutes

09:08
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).